Telix Pharmaceuticals Ltd — Share Issue/Capital Change 2022

Nov 6, 2022

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

TELIX PHARMACEUTICALS LIMITED

Date of this announcement

Monday November 07, 2022

The +securities the subject of this notification are:

==> picture [8 x 9] intentionally omitted <==

Unquoted options that have been exercised or other unquoted +convertible securities that have been converted

Total number of +securities to be issued/transferred

		Total number of
ASX +security		+securities to be
code	Security description	issued/transferred	Issue date
TLX	ORDINARY FULLY PAID	194,972	03/11/2022

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

1 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

TELIX PHARMACEUTICALS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type

ACN

Registration number

616620369

1.3 ASX issuer code

TLX

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

7/11/2022

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

2 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

==> picture [8 x 8] intentionally omitted <==

Unquoted options that have been exercised or other unquoted +convertible securities that have been converted

2.2b The +securities being issued, transferred or re-classified as a result of the options being exercised or other +convertible securities being converted are:

==> picture [8 x 8] intentionally omitted <==

securities that have already been quoted on ASX ("existing class")

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

3 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

==> picture [9 x 8] intentionally omitted <==

A transfer of existing +securities

The underlying securities being received by the holder are: Already quoted by ASX

Existing +securities converting into an existing class

FROM (Existing Class) ASX +Security code and description

TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL

TO (Existing Class) ASX +Security code and description

TLX : ORDINARY FULLY PAID

Please state the number of options The first date the options were The last date the options were that were exercised or other exercised or other +convertible exercised or other +convertible +convertible securities that were securities were converted securities were converted converted 26/10/2022 3/11/2022 125,000

Is this all of the options or other +convertible securities on issue of that type? No

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No

Date the +securities the subject of this notification were issued/transferred

3/11/2022

Any other information the entity wishes to provide about the +securities the subject of this notification

125,000 Share Rights (TLXAN) were exercised for the transfer of 125,000 Shares which were already on issue and held by the Telix Pharmaceuticals Employee Share Trust.

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

4 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Issue details

Number of +securities

125,000

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

==> picture [9 x 9] intentionally omitted <==

A transfer of existing +securities

The underlying securities being received by the holder are: Already quoted by ASX

Existing +securities converting into an existing class

FROM (Existing Class) ASX +Security code and description

TLXAG : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

TO (Existing Class) ASX +Security code and description TLX : ORDINARY FULLY PAID Please state the number of options The first date the options were The last date the options were that were exercised or other exercised or other +convertible exercised or other +convertible +convertible securities that were securities were converted securities were converted converted 26/10/2022 3/11/2022 82,769 Is this all of the options or other +convertible securities on issue of that type? No Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No

Date the +securities the subject of this notification were issued/transferred

3/11/2022

Any other information the entity wishes to provide about the +securities the subject of this notification

82,769 Options with an exercise price of $1.09 each (TLXAG) were exercised via terms of cashless exercise provision for the transfer of 69,972 Shares which were already on issue and held by the Telix Pharmaceuticals Employee Share Trust.

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

5 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Issue details

==> picture [21 x 22] intentionally omitted <==

Number of +securities

69,972

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

6 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +Securities (Total number of each +class of +securities quoted)

	Total number of
ASX +security code and description	+securities on issue
TLX : ORDINARY FULLY PAID	313,107,940

4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
TLXAJ : OPTION EXPIRING 30-JUN-2024 EX $1.83	1,300,000
TLXAI : OPTION EXPIRING 12-JAN-2024 EX $2.23	3,280,000
TLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL	80,000
TLXAG : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	3,012,231
TLXAP : SHARE RIGHTS	125,000
TLXAO : SHARE APPRECIATION RIGHTS	2,493,082
TLXAH : OPTION EXPIRING 03-NOV-2023 EX $2.30	1,310,000
TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37	957,992
TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL	100,000
TLXAL : OPTION EXPIRING 27-JAN-2026 EX $4.38	1,604,281

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

7 / 7